TITLE

No association between the functional CARD4 insertion! deletion polymorphism and inflammatory bowel diseases in the German population

AUTHOR(S)
Franke, A.; Ruether, A.; Wedemeyer, N.; Karisen, T. H.; Nebel, A.; Schreiber, S.
PUB. DATE
November 2006
SOURCE
Gut;Nov2006, Vol. 55 Issue 11, p1679
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article explains the disassociation between the functional CARD15 insertion or deletion polymorphism and inflammatory bowel diseases in the German population. According to sources, inflammatory bowel diseases are represented by two main subtypes, Crohn's disease (CD) and ulcerative colitis. Based from observations, identification of functional CARD15 variants revealed the important role of impaired barrier integrity and host defence in the pathogenesis of CD and other inflammatory diseases.
ACCESSION #
23149289

 

Related Articles

  • GENOTYPES AND PHENOTYPES IN CROHN'S DISEASE: DO THEY HELP IN CLINICAL MANAGMENT. Gasche, C.; Grundtner, P. // Gut;Jan2005, Vol. 54 Issue 1, p162 

    The article reports that the various subforms of Crohn's disease have not been recognised until recently. Historically, colonic Crohn's disease was not distinguished from ulcerative colitis. Approximately 30 years ago, the first studies highlighted the diverse natural history of colonic and...

  • Utilization of Health-Care Resources by Patients With IBD in Manitoba: A Profile of Time Since Diagnosis. Longobardi, Teresa; Bernstein, Charles N. // American Journal of Gastroenterology;Aug2007, Vol. 102 Issue 8, p1683 

    OBJECTIVES: We tested the hypothesis of nonlinear longitudinal trends in health-care utilization by individuals with Crohn's disease (CD) and ulcerative colitis (UC) in Manitoba. METHODS: Administrative databases were used to report resource use in 2000/1. A total of 5,485 cases of CD and UC and...

  • An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North Indians. Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Midha, Vandana; Sood, Ajit; Amre, Devendra; Juyal, Ramesh C.; BK, Thelma // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of...

  • A Comprehensive Evaluation of Colonic Mucosal Isolates of Sutterella wadsworthensis from Inflammatory Bowel Disease. Mukhopadhya, Indrani; Hansen, Richard; Nicholl, Charlotte E.; Alhaidan, Yazeid A.; Thomson, John M.; Berry, Susan H.; Pattinson, Craig; Stead, David A.; Russell, Richard K.; El-Omar, Emad M.; Hold, Georgina L. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Inflammatory bowel disease (IBD) arises in genetically susceptible individuals as a result of an unidentified environmental trigger, possibly a hitherto unknown bacterial pathogen. Twenty-six clinical isolates of Sutterella wadsworthensis were obtained from 134 adults and 61 pediatric patients...

  • A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden, Robert J.; Verhoef, Marja J.; Best, Allan; Pocobelli, Gaia // BMC Gastroenterology;2003, Vol. 3, p10 

    Background: There is a general lack of information on the care of inflammatory bowel disease (IBD) in a broad, geographically diverse, non-clinic population. The purposes of this study were (1) to compare a sample drawn from the membership of a national Crohn's and Colitis Foundation to...

  • Inflammatory bowel disease.  // Good Health (Australia Edition);Jan2013, p127 

    The article presents information on inflammatory bowel disease (IBD) , its causes and what can be done to avoid it. IBD is used for describing two chronic disorders including ulcerative colitis and Crohn's disease. However, the causes of ulcerative colitis and Crohn's disease are not known. It...

  • Evolutioninthe Pharmacogenetics and Pharmacogenomics of Inflammatory Bowel Disease - Order Slowly Rises from the Chaos. Poppers, D. M.; Scherl, E. J. // Current Pharmacogenomics;Dec2006, Vol. 4 Issue 4, p301 

    The management of inflammatory bowel disease (IBD) remains challenging due to the varied clinical manifes-tations of Crohn's disease (CD) and ulcerative colitis (UC). The development of new modalities in therapy is promising, with immunomodulator-based approaches rising to a more prominent...

  • Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases. Mudter, Jonas; Weigmann, Benno; Bartsch, Brigitte; Kiesslich, Ralf; Strand, Dennis; Galle, Peter R.; Lehr, Hans A.; Schmidt, Jan; Neurath, Markus F. // American Journal of Gastroenterology;Jan2005, Vol. 100 Issue 1, p64 

    OJECTIVES: Cytokine signaling pathways involving transcription factors of the signal transducers and activators of transcription (STAT) family play a key role in the pathogenesis of inflammatory bowel diseases (IBD). STAT proteins are latent cytoplasmic transcription factors that induce...

  • Ultrasonography of chronic inflammatory bowel diseases. Valette, P.-J.; Rioux, M.; Pilleul, F.; Saurin, J.-C.; Fouque, P.; Henry, L. // European Radiology;Oct2001, Vol. 11 Issue 10, p1859 

    Advances in the understanding of bowel appearances with high-resolution sonography have led to consideration of this technique as an important tool for bowel disease assessment. Ultrasonography may display the transformation of the intestinal wall from normal to pathological state in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics